Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients
Autor/a
Aldámiz-Echevarría, Teresa
González-García, Juan
Von Wichmann, Miguel A.
Crespo, Manel
López-Aldeguer, José
Quereda, Carmen
Téllez, María J.
Galindo, María J.
Sanz, José
Santos, Ignacio
Guardiola Tey, Josep Maria
Bellón, José M.
Montes, Marisa
Berenguer, Juan
GESIDA HIV-HCV Cohort Study Group
Data de publicació
2015ISSN
1665-2681
Resum
Background and rationale for the study. We assessed the association of CD4+ T-cell counts and HIV-RNA onsustained viral response (SVR) after therapy with pegylated interferon and ribavirin (PR) in HIV/HCV coin-fected patients. We examined two large cohorts of coinfected patients treated with PR in Spain between2000 and 2008. SVR was defined as undetectable HCV-RNA at 24 weeks after the end of PR. Results.Westudied 1682 patients, of whom 38% achieved SVR. Baseline factors independently associated with reducedodds of SVR included genotype 1 or 4, HCV-RNA > 500,000 IU/mL, advanced liver fibrosis, CDC clinical cate-gory C, and detectable HIV-RNA. By multivariate logistic regression analysis, we found that, in comparisonwith patients with combination antiretroviral therapy (cART) and undetectable HIV-RNA, the odds ratio[95% confidence interval (CI)] of SVR was 0.56 (0.41-0.78) for cART and detectable HIV-RNA, 0.86 (0.56-2.57)for no-cART and detectable HIV-RNA, and 1.38 (0.74-2.57) for no-cART and undetectable HIV-RNA. Conclu-sions.Detectable HIV-RNA, but not CD4+ T-cell count, was associated with reduced odds of SVR. However,this finding was only confirmed for cART and detectable HIV-RNA, raising the question as whether this rep-resents a true association of HIV-RNA on response to PR or a spurious association due to poor adherenceto treatment.
Tipus de document
Article
Versió del document
Versió publicada
Llengua
English
Matèries (CDU)
61 - Medicina
616.9 - Malalties infeccioses i contagioses. Febres
Paraules clau
Hepatitis C
Virus de la immunodeficiència humana
Interferó pegilat
Resposta viral sostinguda
Hepatitis C crònica
Hepatitis C
Virus de la inmunodeficiencia humana
Interferón pegilado
Respuesta viral sostenida
Hepatitis C crónica
Hepatitis C
Human immunodeficiency virus
Pegilat interfered
Sustained viral response
Chronic hepatitis C
Pàgines
6
Publicat per
Elsevier
Col·lecció
14; 4
Publicat a
Annals of Hepatology
Citació
Aldámiz-Echevarría, Teresa; González-García, Juan; Von Wichmann, Miguel A. [et al.]. Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients. Annals of Hepatology, 2015, 14(4), p. 464-469. Disponible en: <https://www.sciencedirect.com/science/article/pii/S1665268119311676?via%3Dihub>. Fecha de acceso: 17 jun. 2021. DOI: 10.1016/S1665-2681(19)31167-6
Aquest element apareix en la col·lecció o col·leccions següent(s)
- Ciències de la Salut [738]
Drets
Under a Creative Commons license
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com https://creativecommons.org/licenses/by-nc-nd/4.0/